These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24746454)

  • 41. Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall.
    Chapet O; Udrescu C; Devonec M; Tanguy R; Sotton MP; Enachescu C; Colombel M; Azria D; Jalade P; Ruffion A
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):72-6. PubMed ID: 23290444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
    Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
    Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
    Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.
    Kim DW; Cho LC; Straka C; Christie A; Lotan Y; Pistenmaa D; Kavanagh BD; Nanda A; Kueplian P; Brindle J; Cooley S; Perkins A; Raben D; Xie XJ; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):509-17. PubMed ID: 24929162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis.
    Miller LE; Efstathiou JA; Bhattacharyya SK; Payne HA; Woodward E; Pinkawa M
    JAMA Netw Open; 2020 Jun; 3(6):e208221. PubMed ID: 32585020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late rectal toxicity.
    Chicas-Sett R; Farga D; Perez-Calatayud MJ; Celada F; Roldan S; Fornes-Ferrer V; Ibanez-Rosello B; Tormo A; Benlloch JM; Perez-Calatayud J
    Brachytherapy; 2017; 16(3):511-517. PubMed ID: 28366276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implantation of a biodegradable rectum balloon implant: tips, Tricks and Pitfalls.
    Vanneste BGL; van De Beek K; Lutgens L; Lambin P
    Int Braz J Urol; 2017; 43(6):1033-1042. PubMed ID: 28338306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity.
    Whalley D; Hruby G; Alfieri F; Kneebone A; Eade T
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e148-54. PubMed ID: 27298241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum?
    Guimas V; Quivrin M; Bertaut A; Martin E; Chambade D; Maingon P; Mazoyer F; Cormier L; Créhange G
    Brachytherapy; 2016; 15(4):406-411. PubMed ID: 27317949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose-escalated prostate cancer radiotherapy.
    van Gysen K; Kneebone A; Alfieri F; Guo L; Eade T
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):511-6. PubMed ID: 24580893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.
    Schutzer ME; Orio PF; Biagioli MC; Asher DA; Lomas H; Moghanaki D
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):96-103. PubMed ID: 25687401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
    Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
    Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How I Do It: Hydrogel spacer placement in men scheduled to undergo prostate radiotherapy.
    Montoya J; Gross E; Karsh L
    Can J Urol; 2018 Apr; 25(2):9288-9293. PubMed ID: 29680009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
    Pinkawa M; Corral NE; Caffaro M; Piroth MD; Holy R; Djukic V; Otto G; Schoth F; Eble MJ
    Radiother Oncol; 2011 Sep; 100(3):436-41. PubMed ID: 21963289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Reply to King et al.
    Mariados N; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):937-9. PubMed ID: 26530768
    [No Abstract]   [Full Text] [Related]  

  • 58. In Regard to Mariados et al.
    King CR; Kamrava M; Wang PC; Steinberg ML
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):936-7. PubMed ID: 26530767
    [No Abstract]   [Full Text] [Related]  

  • 59. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
    Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
    Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
    Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.